I-SPY 2.2 is working. Why aren’t others replicating the design?
PRODUCT DEVELOPMENT | REPRINT FROM OCT. 04, 2024 BY LAUREN MARTZ, EXECUTIVE DIRECTOR, BIOPHARMA INTELLIGENCE The I-SPY clinical trials are creating a roadmap for a
PRODUCT DEVELOPMENT | REPRINT FROM OCT. 04, 2024 BY LAUREN MARTZ, EXECUTIVE DIRECTOR, BIOPHARMA INTELLIGENCE The I-SPY clinical trials are creating a roadmap for a
SEATTLE, August 21, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare Collaborative™ (QLHC), today announced the